An Extension to Study MD7108240
NCT00733304
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Degeneration
Interventions
DRUG:
Pazopanib
Sponsor
GlaxoSmithKline